2011, Número 4
<< Anterior Siguiente >>
Rev Hosp Jua Mex 2011; 78 (4)
Enfermedad de moyamoya. Reporte de un caso clínico y revisión bibliográfica
Gil MG, Del Castillo MJA, García RJ
Idioma: Español
Referencias bibliográficas: 24
Paginas: 249-253
Archivo PDF: 247.17 Kb.
RESUMEN
Moyamoya es una enfermedad progresiva que se caracteriza por estenosis de la arteria carótida unilateral o bilateral de causa
desconocida. Se presenta en niños frecuentemente como un ataque de isquemia transitoria, con presencia de un déficit focal
neurológico. Se describe el caso de un niño de dos años, el cual presentó déficit focal neurológico secundario a vasculopatía por
moyamoya asociado a trisomía 21.
REFERENCIAS (EN ESTE ARTÍCULO)
Yamauchi T, Tada M, Houkin K, Tanaka T, Nakamura Y, Kuroda S, Abe H, et al. Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke 2000; 31: 930-5.
Ikeda H, Sasaki T, Yoshimoto T, Fujui M, Arinami T. Mapping of a familial moyamoya disease gene to chromosome 3p24- p26. Am J Hum Genet 1999; 64: 533-7.
Fukuyama Y, Imaizumi T, Osawa M. A long-term prognosis of children with TIA type spontaneous occlusion of the circle of Willis (moyamoya disease). Japan: Annual report 1993, their research committee on spontaneous occlusion of the circle of Willis (Moyamoya disease) of the Ministry of Health and Welfare; 1993, p. 14-7.
Takeuchi K, Shimizu K. Hypogenesis of bilateral internal carotid arteries. No To Shinkei 1957; 9: 37-43.
Suzuki J, Takaku A. Cerebrovascular ‘moyamoya’ disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969; 20: 288-99.
Uchino K, Johnston SC, Becker KJ, et al. Moyamoya disease in Washington state and California. Neurology 2005; 65: 956-8.
Wakai K, Tamakoshi A, Ikezaki K, et al. Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg 1997; 99: S1-S5.
Mineharu Y, Takenaka K, Yamakawa H, et al. Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting. J Neurol Neurosurg Psychiatry 2006; 77: 1025-9.
Vermer S, Van Oostrom CG, Boetes C, et al. A unique case of PHACES syndrome confirming the assumption that PHACES syndrome and the sternal malformation-vascular dysplasia association are part of the same spectrum of malformations. Clin Dysmorphol 2005; 14: 203-6.
Fujiwara J, Nakahara S, Enomoto T, et al. The effectiveness of O2 administration for transient ischemic attacks in moyamoya disease in children. Childs Nerv Syst 1996; 12: 69-75.
Mugikura S, Takahashi S, Higano S, et al. Predominant involvement of the ipsilateral anterior and posterior circulations in moyamoya disease. Stroke 2002; 33: 397-400.
Fukui M, Kono S, Sueishi K, et al. Moyamoya disease. Neuropathology 2000; 20: S61-S64.
Adams HP, del Zoppo D, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke. Stroke 2007; 38: 1655-95.
Fung LE, Thompson D, Ganesan V. Revascularization surgery for pediatric moyamoya: a review of the literature. Childs Nerv Syst 2005; 21: 358-64.
Rison R. Fluctuating hemiparesis secondary to moyamoya phenomenon in a child with Down syndrome: a case report. Cases J 2008; 1: 240.
Braun KP, Kappelle LJ, Kirkham FJ, et al. Diagnostic pitfalls in pediatric ischemic stroke. Dev Med Child Neurol 2006; 48: 985-90.
Lee BC, Park TS, Kaufman BA. MR angiography in pediatric neurological disorders. Pediatr Radiol 1995; 25: 409-19.
Janda P, Bellew J, Veerappan V. Moyamoya disease: Case report and literature review. J Am Osteopath Assoc 2009; 109: 545-51.
Chaanine A, Hugunenq C, Lena G. Neurological complications in Down syndrome. Archives de pédiatrie 2008; 15: 388-96.
Acute hemiplegia in an adolescent. Archives de Pédiatrie 2009; 16: 46.
Andrew J, Smith E, Robertson R. Moyamoya syndrome associated with Down syndrome: Outcome after surgical revascularization. Pediatrics 2005; 116; e694-e701.
Fung AV, Kwong KL, Tsui EYK. Moyamoya syndrome in a child with down syndrome. Hong Kong Med J 2003; 9: 63-6.
Takanashi J, Sugita K. Evaluation of magnetic resonance angiography with selective maximum intensity projection in patients with childhood moya moya disease. Europ J Paediatric Neurol 1998; 2: 83-9.
Constantin R, Vera P. Analysis of ACTA 2 in European Moyamoya disease patients. European Journal of Paediatric neurology 2011; 15: 117-22.